Publications by authors named "Fadhil A-Hamad Saleh-Arong"
Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled Trial.
Yupin Suputtamongkol Panisadee Avirutnan Dumrong Mairiang Nasikarn Angkasekwinai Kannika Niwattayakul Fadhil A-Hamad Saleh-Arong
Clin Infect Dis
May 2021
Background: Dengue is the most significant mosquito-borne viral disease; there are no specific therapeutics. The antiparasitic drug ivermectin efficiently inhibits the replication of all 4 dengue virus serotypes in vitro.
Methods: We conducted 2 consecutive randomized, double-blind, placebo-controlled trials in adult dengue patients to evaluate safety and virological and clinical efficacies of ivermectin.